X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3505) 3505
Publication (670) 670
Book Chapter (53) 53
Book Review (36) 36
Dissertation (21) 21
Conference Proceeding (9) 9
Government Document (4) 4
Data Set (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2357) 2357
humans (2051) 2051
animals (1256) 1256
hdac inhibitors (1174) 1174
hdac (1129) 1129
histone deacetylase inhibitors (971) 971
histone deacetylase inhibitors - pharmacology (939) 939
cancer (926) 926
acetylation (823) 823
histone deacetylases - metabolism (823) 823
oncology (804) 804
histone deacetylase (764) 764
biochemistry & molecular biology (760) 760
apoptosis (750) 750
cell line, tumor (701) 701
hdac inhibitor (646) 646
mice (602) 602
cell biology (575) 575
expression (573) 573
epigenetics (530) 530
gene expression (528) 528
hydroxamic acids - pharmacology (516) 516
article (476) 476
pharmacology & pharmacy (453) 453
gene-expression (423) 423
antineoplastic agents - pharmacology (422) 422
apoptosis - drug effects (415) 415
female (412) 412
proteins (410) 410
chemistry, medicinal (409) 409
male (402) 402
valproic acid (402) 402
histones - metabolism (393) 393
histone deacetylase inhibitor (384) 384
analysis (383) 383
chromatin (378) 378
cell proliferation - drug effects (364) 364
suberoylanilide hydroxamic acid (338) 338
dna methylation (324) 324
research (318) 318
histones (312) 312
histone deacetylase inhibitors - therapeutic use (292) 292
neurosciences (280) 280
transcription (267) 267
enzyme inhibitors - pharmacology (265) 265
histone deacetylase inhibitors - chemistry (260) 260
histone deacetylases - genetics (256) 256
activation (255) 255
histone deacetylases (254) 254
cells (253) 253
care and treatment (248) 248
epigenetic inheritance (248) 248
enzymes (246) 246
inhibitors (246) 246
health aspects (245) 245
in-vitro (225) 225
dose-response relationship, drug (219) 219
vorinostat (219) 219
structure-activity relationship (218) 218
differentiation (217) 217
cell cycle (215) 215
chemistry, organic (211) 211
rats (211) 211
epigenesis, genetic (208) 208
in-vivo (208) 208
hdacs (203) 203
methylation (203) 203
genetic aspects (202) 202
genes (186) 186
tumors (186) 186
growth (185) 185
antineoplastic agents - therapeutic use (178) 178
phosphorylation (178) 178
neoplasms - drug therapy (173) 173
therapy (173) 173
histone acetylation (169) 169
inhibition (169) 169
signal transduction (169) 169
genetics & heredity (167) 167
antineoplastic agents - chemistry (165) 165
chemotherapy (165) 165
hdac inhibition (165) 165
valproic acid - pharmacology (164) 164
drug design (161) 161
nf-kappa-b (161) 161
cells, cultured (160) 160
cell survival - drug effects (158) 158
acetylation - drug effects (156) 156
blotting, western (156) 156
cell line (155) 155
inflammation (155) 155
down-regulation (152) 152
biology (150) 150
physiological aspects (150) 150
drug synergism (148) 148
histone deacetylase inhibitors - chemical synthesis (148) 148
kinases (147) 147
histone deacetylases - chemistry (146) 146
hematology (145) 145
trichostatin-a (145) 145
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3551) 3551
Japanese (6) 6
Chinese (3) 3
French (3) 3
Korean (3) 3
German (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncotarget, ISSN 1949-2553, 06/2018, Volume 9, Issue 49, pp. 29193 - 29207
While several systemic therapies are approved for cutaneous T cell lymphoma (CTCL), a non-Hodgkin lymphoma of skin-homing T cells that may involve lymph nodes... 
HDAC inhibition | CTCL | BET inhibition | Apoptosis
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 09/2019, Volume 104, Issue 10, pp. 2061 - 2074
Despite recent advances in the treatment of multiple myeloma, patients with this disease still inevitably relapse and become refractory to existing therapies.... 
CELLS | SIGNALING PATHWAYS | CONTRIBUTE | PHOSPHORYLATION | RAS MUTATIONS | VENETOCLAX | MCL-1 | STABILITY | MECHANISMS | HEMATOLOGY | HDAC
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 2017, Volume 292, Issue 43, pp. 17897 - 17908
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 07/2016, Volume 35, Issue 29, pp. 3781 - 3795
PI3K (phosphoinositide 3-kinase)/AKT and RAS/MAPK (mitogen-activated protein kinase) pathway coactivation in the prostate epithelium promotes both... 
ANDROGEN RECEPTOR | DNA-BINDING | STEM-CELLS | PTEN LOSS | ACTIVATION | ACETYLATION | HMGI-C | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY | BREAST-CANCER | ONCOLOGY | GENETICS & HEREDITY | INCREASED SURVIVAL | EXPRESSION | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Epithelial-Mesenchymal Transition - drug effects | Male | Phosphatidylinositol 3-Kinases - metabolism | Epithelial-Mesenchymal Transition - genetics | Prostatic Neoplasms, Castration-Resistant - genetics | Neoplasm Metastasis | Indoles - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Hydroxamic Acids - pharmacology | Disease Models, Animal | Proto-Oncogene Proteins p21(ras) - metabolism | PTEN Phosphohydrolase - genetics | PTEN Phosphohydrolase - metabolism | Gene Expression Profiling - methods | Mice, Transgenic | Prostatic Neoplasms, Castration-Resistant - drug therapy | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Prostatic Neoplasms, Castration-Resistant - metabolism | Blotting, Western | Mice, Knockout | Animals | Signal Transduction - drug effects | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Mice, Inbred NOD | Mitogen-Activated Protein Kinases - metabolism | Proteins | Kinases | Drug resistance | Prostate cancer | HDAC inhibitor | epithelial-mesenchymal transition (EMT) | metastasis | epigenetics | castration-resistant prostate cancer (CRPC)
Journal Article
Circulation, ISSN 0009-7322, 03/2014, Volume 129, Issue 10, pp. 1139 - 1151
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 11/2009, Volume 111, Issue 4, pp. 976 - 987
Journal Article